VK

Vikas Kumar Dubey

Active Director Director DIN 11797326
DIN 11797326 First appointment Jun 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Vikas Kumar Dubey

Vikas Kumar Dubey is a Director at Oncogenix Pharmaceutical Private Limited (since 2026).

DIN 11797326
Primary Designation Director
First Appointment 30 Jun 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Jun 20262026Active

Directorship timeline

Open interactive timeline →
Oncogenix Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Vikas Kumar Dubey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vikas Kumar Dubey

Vikas Kumar Dubey currently holds 1 directorship: Oncogenix Pharmaceutical Private Limited (Director, since 30 Jun 2026).

Vikas Kumar Dubey was first appointed on 30 Jun 2026 as Director at Oncogenix Pharmaceutical Private Limited.

The current boards of Vikas Kumar Dubey's companies include Bhavesh Devshibhai Dudhat (Oncogenix Pharmaceutical Private Limited), Hiteshkumar Madhubhai Kachhadiya (Oncogenix Pharmaceutical Private Limited), Nitinkumar Chaturbhai Malaviya (Oncogenix Pharmaceutical Private Limited), Piyushbhai Kalubhai Gajera (Oncogenix Pharmaceutical Private Limited), Vijay Bharatbhai Bhoot (Oncogenix Pharmaceutical Private Limited), Vishalkumar Chhaganbhai Patel (Oncogenix Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available